{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T01:09:51Z","timestamp":1791940191838,"version":"4.3.4"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"King Abdullah II Fund for Development","award":["6-2018"],"award-info":[{"award-number":["6-2018"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Prostaglandins &amp; Other Lipid Mediators"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.prostaglandins.2019.02.003","type":"journal-article","created":{"date-parts":[[2019,2,11]],"date-time":"2019-02-11T11:50:03Z","timestamp":1549885803000},"page":"14-21","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Effects of nonsteroidal anti-inflammatory drugs on the expression of arachidonic acid-metabolizing Cyp450 genes in mouse hearts, kidneys and livers"],"prefix":"10.1016","volume":"141","author":[{"given":"Yazun Bashir","family":"Jarrar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qais","family":"Jarrar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulqader","family":"abed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Abu-Shalhoob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prostaglandins.2019.02.003_bib0005","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/258209","article-title":"Current perspectives in NSAID-induced gastropathy","volume":"2013","author":"Sinha","year":"2013","journal-title":"Mediators Inflamm."},{"issue":"Suppl 3","key":"10.1016\/j.prostaglandins.2019.02.003_bib0010","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1186\/ar4174","article-title":"Use of NSAIDs in treating patients with arthritis","volume":"15","author":"Crofford","year":"2013","journal-title":"Arthritis Res. Ther."},{"issue":"Suppl","key":"10.1016\/j.prostaglandins.2019.02.003_bib0015","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1194\/jlr.R800042-JLR200","article-title":"Cyclooxygenases: structural and functional insights","volume":"50","author":"Rouzer","year":"2009","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.prostaglandins.2019.02.003_bib0020","doi-asserted-by":"crossref","first-page":"17244","DOI":"10.3390\/ijms131217244","article-title":"Prodrugs of nonsteroidal anti-inflammatory drugs (NSAIDs), more than meets the eye: a critical review","volume":"13","author":"Qandil","year":"2012","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.prostaglandins.2019.02.003_bib0025","first-page":"2429","article-title":"Dysmenorrhoea","author":"Proctor","year":"2006","journal-title":"Clin. Evid."},{"key":"10.1016\/j.prostaglandins.2019.02.003_bib0030","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/536962","article-title":"NSAIDs and cardiovascular diseases: role of reactive oxygen species","volume":"2015","author":"Ghosh","year":"2015","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.prostaglandins.2019.02.003_bib0035","first-page":"25","article-title":"Risk of stroke associated with nonsteroidal anti-inflammatory drugs","volume":"10","author":"Park","year":"2014","journal-title":"Vasc. Health Risk Manag."},{"key":"10.1016\/j.prostaglandins.2019.02.003_bib0040","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1177\/2042098617690485","article-title":"Cardiovascular and cerebrovascular risk with nonsteroidal anti-inflammatory drugs and cyclooxygenase 2 inhibitors: latest evidence and clinical implications","volume":"8","author":"Fanelli","year":"2017","journal-title":"Ther. Adv. Drug Saf."},{"key":"10.1016\/j.prostaglandins.2019.02.003_bib0045","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/j.1365-2125.2009.03469.x","article-title":"Aldosterone glucuronidation by human liver and kidney microsomes and recombinant UDP-glucuronosyltransferases: inhibition by NSAIDs","volume":"68","author":"Knights","year":"2009","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.prostaglandins.2019.02.003_bib0050","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1111\/j.1538-7836.2009.03582.x","article-title":"Prothrombotic effects of diclofenac on arteriolar platelet activation and thrombosis in vivo","volume":"7","author":"Struthmann","year":"2009","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.prostaglandins.2019.02.003_bib0055","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.plefa.2013.06.008","article-title":"Identification of cytochrome P450s involved in the metabolism of arachidonic acid in human platelets","volume":"89","author":"Jarrar","year":"2013","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"10.1016\/j.prostaglandins.2019.02.003_bib0060","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1540\/jsmr.41.175","article-title":"Role of 20-hydroxyeicosatetraenoic acid (20-HETE) in vascular system","volume":"41","author":"Miyata","year":"2005","journal-title":"J. Smooth Muscle Res."},{"key":"10.1016\/j.prostaglandins.2019.02.003_bib0065","doi-asserted-by":"crossref","first-page":"17017","DOI":"10.1073\/pnas.1011278107","article-title":"Metabolic profiling of murine plasma reveals an unexpected biomarker in rofecoxib-mediated cardiovascular events","volume":"107","author":"Liu","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.prostaglandins.2019.02.003_bib0070","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1124\/jpet.117.243618","article-title":"The Blood Pressure-Lowering Effect of 20-HETE Blockade in Cyp4a14(-\/-) Mice Is Associated with Natriuresis","volume":"363","author":"Pandey","year":"2017","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.prostaglandins.2019.02.003_bib0075","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.yjmcc.2014.05.016","article-title":"Epoxyeicosatrienoic acids and cardioprotection: the road to translation","volume":"74","author":"Oni-Orisan","year":"2014","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.prostaglandins.2019.02.003_bib0080","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.pharmthera.2009.12.002","article-title":"Effect of cytochrome P450 polymorphism on arachidonic acid metabolism and their impact on cardiovascular diseases","volume":"125","author":"Zordoky","year":"2010","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.prostaglandins.2019.02.003_bib0085","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1124\/dmd.112.046631","article-title":"Chronic doxorubicin cardiotoxicity modulates cardiac cytochrome P450-mediated arachidonic acid metabolism in rats","volume":"40","author":"Alsaad","year":"2012","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.prostaglandins.2019.02.003_bib0090","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.xphs.2017.09.020","article-title":"Drug-disease interaction: effect of inflammation and nonsteroidal anti-inflammatory drugs on cytochrome P450 metabolites of arachidonic acid","volume":"107","author":"Aghazadeh-Habashi","year":"2018","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.prostaglandins.2019.02.003_bib0095","series-title":"Guide to the Care and Use of Experimental Animals","author":"Canadian Council on Animal Care","year":"1980"},{"key":"10.1016\/j.prostaglandins.2019.02.003_bib0100","first-page":"3574","article-title":"Rodent model choice has major impact on variability of standard preclinical readouts associated with diabetes and obesity research","volume":"8","author":"Jensen","year":"2016","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.prostaglandins.2019.02.003_bib0105","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4103\/0976-0105.177703","article-title":"A simple practice guide for dose conversion between animals and human","volume":"7","author":"Nair","year":"2016","journal-title":"J. Basic Clin. Pharm."},{"key":"10.1016\/j.prostaglandins.2019.02.003_bib0110","doi-asserted-by":"crossref","first-page":"D54","DOI":"10.1093\/nar\/gki031","article-title":"Entrez Gene: gene-centered information at NCBI","volume":"33","author":"Maglott","year":"2005","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.prostaglandins.2019.02.003_bib0115","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/j.yjmcc.2012.03.006","article-title":"Doxorubicin-induced cardiomyopathy: from molecular mechanisms to therapeutic strategies","volume":"52","author":"Octavia","year":"2012","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.prostaglandins.2019.02.003_bib0120","doi-asserted-by":"crossref","first-page":"483","DOI":"10.2147\/DMSO.S172664","article-title":"Alterations in the gene expression of drug and arachidonic acid-metabolizing Cyp450 in the livers of controlled and uncontrolled insulin-dependent diabetic mice","volume":"11","author":"Jarrar","year":"2018","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"10.1016\/j.prostaglandins.2019.02.003_bib0125","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.prostaglandins.2019.02.003_bib0130","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jcf.2012.08.014","article-title":"Effect of allergy and inflammation on eicosanoid gene expression in CFTR deficiency","volume":"12","author":"Bickford","year":"2013","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.prostaglandins.2019.02.003_bib0135","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1096\/fj.10-168971","article-title":"Fluid shear stress primes mouse embryonic stem cells for differentiation in a self-renewing environment via heparan sulfate proteoglycans transduction","volume":"25","author":"Toh","year":"2011","journal-title":"FASEB J."},{"key":"10.1016\/j.prostaglandins.2019.02.003_bib0140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0023199","article-title":"P38 mitogen-activated protein kinase inhibitor, FR167653, inhibits parathyroid hormone related protein-induced osteoclastogenesis and bone resorption","volume":"6","author":"Tao","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.prostaglandins.2019.02.003_bib0145","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1136\/bmj.287.6400.1182","article-title":"Enteritis and colitis associated with mefenamic acid","volume":"287","author":"Hall","year":"1983","journal-title":"Br Med J (Clin Res Ed)"},{"key":"10.1016\/j.prostaglandins.2019.02.003_bib0150","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1080\/01913123.2017.1349850","article-title":"Comparative ultrastructural hepatic alterations induced by free and liposome-encapsulated mefenamic acid","volume":"41","author":"Jarrar","year":"2017","journal-title":"Ultrastruct. Pathol."},{"key":"10.1016\/j.prostaglandins.2019.02.003_bib0155","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/5253623","article-title":"Hepatotoxicity of nonsteroidal anti-inflammatory drugs: a systematic review of randomized controlled trials","volume":"2018","author":"Sriuttha","year":"2018","journal-title":"Int. J. Hepatol."},{"key":"10.1016\/j.prostaglandins.2019.02.003_bib0160","doi-asserted-by":"crossref","first-page":"502","DOI":"10.2174\/1570161114666160728093323","article-title":"Use of non-selective non-steroidal anti-inflammatory drugs in relation to cardiovascular events","volume":"14","author":"Kontogiorgis","year":"2016","journal-title":"A Syst. Pharmacoepidemiol. Rev. Curr. Vasc. Pharmacol."},{"key":"10.1016\/j.prostaglandins.2019.02.003_bib0165","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/j.1440-1681.2004.03961.x","article-title":"Lipophilicity affects the pharmacokinetics and toxicity of local anaesthetic agents administered by caudal block","volume":"31","author":"Nava-Ocampo","year":"2004","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.prostaglandins.2019.02.003_bib0170","doi-asserted-by":"crossref","first-page":"486","DOI":"10.2174\/156802612799436641","article-title":"General molecular biology and architecture of nuclear receptors","volume":"12","author":"Pawlak","year":"2012","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.prostaglandins.2019.02.003_bib0175","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.cellsig.2011.02.007","article-title":"Cell signaling pathways for the regulation of GATA4 transcription factor: implications for cell growth and apoptosis","volume":"23","author":"Suzuki","year":"2011","journal-title":"Cell. Signal."},{"key":"10.1016\/j.prostaglandins.2019.02.003_bib0180","first-page":"294","article-title":"20-Hydroxyeicosatetraenoic acid induces apoptosis in neonatal rat cardiomyocytes through mitochondrial-dependent pathways","volume":"57","author":"Bao","year":"2011","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.prostaglandins.2019.02.003_bib0185","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/onc.2009.421","article-title":"The role of COX-2 in intestinal inflammation and colorectal cancer","volume":"29","author":"Wang","year":"2010","journal-title":"Oncogene"},{"key":"10.1016\/j.prostaglandins.2019.02.003_bib0190","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1161\/01.CIR.98.2.100","article-title":"Induction of cyclooxygenase-2 and activation of nuclear factor-kappaB in myocardium of patients with congestive heart failure","volume":"98","author":"Wong","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.prostaglandins.2019.02.003_bib0195","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1038\/jcbfm.2015.75","article-title":"20-HETE is associated with unfavorable outcomes in subarachnoid hemorrhage patients","volume":"35","author":"Donnelly","year":"2015","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.prostaglandins.2019.02.003_bib0200","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/ki.2008.600","article-title":"Protective effect of 20-HETE analogues in experimental renal ischemia reperfusion injury","volume":"75","author":"Regner","year":"2009","journal-title":"Kidney Int."},{"key":"10.1016\/j.prostaglandins.2019.02.003_bib0205","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1097\/00004872-199505000-00012","article-title":"Role of changes in renal hemodynamics and P-450 metabolites of arachidonic acid in the reversal of one-kidney, one clip hypertension","volume":"13","author":"Zou","year":"1995","journal-title":"J. Hypertens."},{"key":"10.1016\/j.prostaglandins.2019.02.003_bib0210","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1681\/ASN.2008010063","article-title":"Association of a CYP4A11 variant and blood pressure in black men","volume":"19","author":"Gainer","year":"2008","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.prostaglandins.2019.02.003_bib0215","first-page":"655","article-title":"Selective inhibition of arachidonic acid epoxidation in vivo","volume":"51","author":"Brand-Schieber","year":"2000","journal-title":"J. Physiol. Pharmacol."},{"key":"10.1016\/j.prostaglandins.2019.02.003_bib0220","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S1098-8823(03)00077-7","article-title":"Role of cytochrome P450-dependent arachidonic acid metabolites in liver physiology and pathophysiology","volume":"72","author":"Sacerdoti","year":"2003","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"10.1016\/j.prostaglandins.2019.02.003_bib0225","doi-asserted-by":"crossref","first-page":"31581","DOI":"10.1074\/jbc.273.47.31581","article-title":"Peroxisome proliferator-activated receptor alpha controls the hepatic CYP4A induction adaptive response to starvation and diabetes","volume":"273","author":"Kroetz","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.prostaglandins.2019.02.003_bib0230","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1172\/JCI8814","article-title":"CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis","volume":"105","author":"Leclercq","year":"2000","journal-title":"J. Clin. Invest."}],"container-title":["Prostaglandins &amp; Other Lipid Mediators"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098882318301114?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098882318301114?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T01:58:57Z","timestamp":1761098337000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098882318301114"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":46,"alternative-id":["S1098882318301114"],"URL":"https:\/\/doi.org\/10.1016\/j.prostaglandins.2019.02.003","relation":{},"ISSN":["1098-8823"],"issn-type":[{"value":"1098-8823","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of nonsteroidal anti-inflammatory drugs on the expression of arachidonic acid-metabolizing Cyp450 genes in mouse hearts, kidneys and livers","name":"articletitle","label":"Article Title"},{"value":"Prostaglandins & Other Lipid Mediators","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prostaglandins.2019.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}